Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the exchange about its 15th Annual General Meeting (AGM) scheduled for Tuesday, 5th August 2025 at 3:00 p.m. (IST), to be held via Video Conference. The company is sending letters to shareholders whose email addresses are not registered, directing them to download the FY 2024-25 Annual Report from the company's website. Key dates include a record date and e-voting cut-off date of 29th July 2025, e-voting window from 2nd August to 4th August 2025, TDS exemption form deadline of 19th July 2025, and dividend payment on or from 7th August 2025. Shareholders holding shares in physical form are urged to update their KYC details with the Registrar (MUFG Intime India).
This is a routine AGM-related disclosure with no material impact on stock price, but it confirms a final dividend will be paid to shareholders on or after 7th August 2025, with eligibility determined by holdings as of 29th July 2025.